Showing 2 of 2 recruiting trials for “autosomal-dominant-hypocalcemia”
Postoperative Hypocalcemia After Thyroidectomy
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
👨⚕️ Calcilytix Medical Director, Calcilytix Therapeutics, Inc., a BridgeBio company📍 5 sites📅 Started Jan 2026View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →